Point32Health and GRAIL Expand Pilot Access to Multi-Cancer Early Detection Test
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read MorePosted by Andy Lundin | Sep 29, 2023 | Cancer |
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read MorePosted by Andy Lundin | Sep 22, 2023 | Diagnostic Technologies |
A study demonstrated clinical utility of Predicine’s MRD liquid biopsy assay in support of Genentech’s Phase 1 Clinical Trial of Divarasib.
Read MorePosted by Chris Wolski | Sep 20, 2023 | Microscopy |
Gestalt’s Mitotic Counting algorithm was trained on over 100,000 individual mitosis and across seven scanner models.
Read MorePosted by Chris Wolski | Sep 19, 2023 | Cancer |
Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to...
Read MorePosted by Andy Lundin | Sep 8, 2023 | Transfusion & Transplantation Tests |
Researchers have developed an electronic device for continuously monitoring the health of transplanted organs in real-time.
Read More